TMCnet News

Executives from Aetna and Trinity Health System added to all-star speaker line-up for Chilmark's Convergence Conference
[August 28, 2017]

Executives from Aetna and Trinity Health System added to all-star speaker line-up for Chilmark's Convergence Conference


BOSTON, Aug. 28, 2017 /PRNewswire/ -- Chilmark Research, with support from Founding Sponsors CareEvolution and Cerner, is thrilled to announce the expanded agenda of the inaugural Convergence Conference to be held in Boston, MA on October 4-6, 2017.

Convergence 2017 by Chilmark Research will held in Boston, MA on October 4-6, 2017. It will highlight examples of innovations in healthcare technology, business models, and delivery systems as the lines between providers and payers continue to blur in response to the inevitable growth of value-based care. Learn more at chilmarkconvergence.com. (PRNewsfoto/Chilmark Research (Convergence))

Gary Loveman, EVP and President of Consumer Health and Services at Aetna, will deliver a payer's perspective on convergence through an overview of Aetna's partnering strategy with providers and how Aetna intends to more deeply support providers, meeting providers where they are in their transition to fee-for-value service models. Here is a peek at some o Aetna's progress so far. 



Daniel J. Roth, M.D., Executive Vice President and Chief Clinical Officer of Trinity Health, has also been confirmed as a keynote following Dr. Loveman. Dr. Roth will provide a rich perspective of one of the nation's largest healthcare systems, detailing some of their approaches, strategic insights, and key lessons learned to date as they follow their path to convergence.

Joining Dr. Loveman and Dr. Roth at this industry-first event are such luminaries as Dr. John Halamka of Beth Israel Deaconess, Dr. Sachin Jain, CEO of CareMore, Paul Black, CEO of Allscripts, and Dr. John Bulger, CMO of Geisinger – and many others representing the innovators in healthcare that are aggressively moving toward a converged model of care – shaping up to be the only feasible approach to meet quadruple aim goals.


Convergence 2017 will highlight examples of innovations in healthcare technology, business models, and delivery systems as the lines between providers and payers continue to blur in response to the inevitable growth of value-based care.

"No other research firm has the depth and background in understanding the complexities of convergence," says John Moore, Founder and Managing Partner of Chilmark Research. "Our Convergence Conference will facilitate the guidance needed for any healthcare organization to successfully pursue their strategic convergence initiatives." 

Registration is currently open for the conference, which will be hosted at the Hyatt Regency Boston. To take advantage of Early Bird registration rates, be sure to register prior to September 4th. Chilmark Research would like to thank its sponsors Cerner, CareEvolution, Geneia LLC, Allscripts, and Epic for their generous support. Media support is being provided by STAT News, Industry Dive, Tech Target and Amendola Communications. To learn more about sponsorship and media opportunities, or for any additional questions, please email John at [email protected].

About Chilmark Research
Chilmark Research is the only industry analyst firm focusing solely on health IT. We combine proven research methodologies with intelligence and insight to provide cogent analyses of the emerging technologies that have the greatest potential to improve healthcare. We do not shy away from making tough calls, and are respected in the industry for our direct and thoughtful commentary. It is with great pleasure that we announce this event in conjunction with our company's ten-year anniversary. For more information visit: www.chilmarkresearch.com/

Media Contact
John Moore
[email protected]
617.823.7623

 

View original content with multimedia:http://www.prnewswire.com/news-releases/executives-from-aetna-and-trinity-health-system-added-to-all-star-speaker-line-up-for-chilmarks-convergence-conference-300509818.html

SOURCE Chilmark Research


[ Back To TMCnet.com's Homepage ]